BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mason R, Crystal R. Pulmonary Cell Biology. Am J Respir Crit Care Med 1998;157:S72-81. [DOI: 10.1164/ajrccm.157.4.nhlbi-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Selo MA, Sake JA, Kim KJ, Ehrhardt C. In vitro and ex vivo models in inhalation biopharmaceutical research - advances, challenges and future perspectives. Adv Drug Deliv Rev 2021;:113862. [PMID: 34256080 DOI: 10.1016/j.addr.2021.113862] [Reference Citation Analysis]
2 Ghanem R, Laurent V, Roquefort P, Haute T, Ramel S, Le Gall T, Aubry T, Montier T. Optimizations of In Vitro Mucus and Cell Culture Models to Better Predict In Vivo Gene Transfer in Pathological Lung Respiratory Airways: Cystic Fibrosis as an Example. Pharmaceutics 2020;13:47. [PMID: 33396283 DOI: 10.3390/pharmaceutics13010047] [Reference Citation Analysis]
3 Sporty JL, Horálková L, Ehrhardt C. In vitro cell culture models for the assessment of pulmonary drug disposition. Expert Opinion on Drug Metabolism & Toxicology 2008;4:333-45. [DOI: 10.1517/17425255.4.4.333] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 6.2] [Reference Citation Analysis]
4 Salomon JJ, Ehrhardt C. Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery. Ther Deliv 2012;3:735-47. [PMID: 22838069 DOI: 10.4155/tde.12.51] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
5 Takahashi K, Mitsui M, Takeuchi K, Uwabe Y, Kobayashi K, Sawasaki Y, Matsuoka T. Preservation of the characteristics of the cultured human type II alveolar epithelial cells. Lung. 2004;182:213-226. [PMID: 15636194 DOI: 10.1007/s00408-004-2504-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
6 Alvarado A, Arce I. Metabolic Functions of the Lung, Disorders and Associated Pathologies. J Clin Med Res 2016;8:689-700. [PMID: 27635172 DOI: 10.14740/jocmr2668w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
7 Groneberg DA, Witt C, Wagner U, Chung KF, Fischer A. Fundamentals of pulmonary drug delivery. Respir Med 2003;97:382-7. [PMID: 12693798 DOI: 10.1053/rmed.2002.1457] [Cited by in Crossref: 150] [Cited by in F6Publishing: 135] [Article Influence: 8.3] [Reference Citation Analysis]
8 Dabbagh K, Laurent GJ, Shock A, Leoni P, Papakrivopoulou J, Chambers RC. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol 2001;186:73-81. [DOI: 10.1002/1097-4652(200101)186:1<73::aid-jcp1002>3.0.co;2-q] [Cited by in Crossref: 52] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
9 Schmitz G, Grandl M. Endolysosomal phospholipidosis and cytosolic lipid droplet storage and release in macrophages. Biochim Biophys Acta 2009;1791:524-39. [PMID: 19146988 DOI: 10.1016/j.bbalip.2008.12.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
10 Groneberg DA, Paul H, Welte T. Novel strategies of aerosolic pharmacotherapy. Exp Toxicol Pathol 2006;57 Suppl 2:49-53. [PMID: 16580826 DOI: 10.1016/j.etp.2006.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
11 Nandkumar MA, Ashna U, Thomas LV, Nair PD. Pulmonary surfactant expression analysis—Role of cell–cell interactions and 3‐D tissue‐like architecture. Cell Biol Int 2015;39:272-82. [DOI: 10.1002/cbin.10389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Hermans C, Bernard A. Lung Epithelium–specific Proteins: Characteristics and Potential Applications as Markers. Am J Respir Crit Care Med 1999;159:646-78. [DOI: 10.1164/ajrccm.159.2.9806064] [Cited by in Crossref: 304] [Cited by in F6Publishing: 288] [Article Influence: 13.8] [Reference Citation Analysis]
13 Anderson N, Borlak J. Drug-induced phospholipidosis. FEBS Lett 2006;580:5533-40. [PMID: 16979167 DOI: 10.1016/j.febslet.2006.08.061] [Cited by in Crossref: 214] [Cited by in F6Publishing: 194] [Article Influence: 14.3] [Reference Citation Analysis]